a medical officer’s approach to nda/bla review (8of15) redi annual conference – may 29-30, 2019
Published 4 years ago • 2.4K plays • Length 34:20Download video MP4
Download video MP3
Similar videos
-
38:21
nda and bla application review process (6of15) redi annual conference – may 29-30, 2019
-
36:06
what can cder do for you? (3of15) redi annual conference – may 29-30, 2019
-
36:55
components of new drug application and biologics license application (5of15) redi– may 29-30, 2019
-
41:30
meetings: pre-submission and special programs (4of15) redi annual conference – may 29-30, 2019
-
7:35:04
redi annual conference 2024: cder (drugs) innovation in medical product development (day 1 of 2)
-
7:13:56
redi annual conference 2024: cder (drugs) innovation in medical product development (day 2 of 2)
-
5:41:06
redi annual conference 2024: cdrh (devices) innovation in medical product development (day 1 of 2)
-
3:35
q&a with the fda ctp {tma 2024}
-
57:45
inside the fda: a clinician's guide to the drug approval process
-
41:31
pre-approval inspections: what to expect when being inspected (15of15) redi – may 29-30, 2019
-
8:03:23
regulatory education for industry (redi) annual conference 2022 - day 4
-
6:04:12
redi annual conference 2024: cber (biologics) innovation in medical product development (day 1 of 2)
-
55:56
electronic common technical document (ectd) and study data (7of15) redi – may 29-30, 2019
-
10:31
ora aligned for the future (1of15) redi – may 29-30, 2019
-
1:10:48
cmc - nda requirements and common pitfalls of blas (14of15) redi – may 29-30, 2019
-
7:46:19
fda regulatory education for industry (redi) annual conference 2023 – drugs day 2
-
6:52:20
redi annual conference 2024: cdrh (devices) innovation in medical product development (day 2 of 2)
-
1:15:49
regulatory education for industry (redi) annual conference 2023 – day 2 – session 2
-
1:42:05
regulatory education for industry (redi) annual conference 2022 - day 1 - part 1
-
7:42:03
redi annual conference 2024: cber (biologics) innovation in medical product development (day 2 of 2)
-
7:42:41
fda regulatory education for industry (redi) annual conference 2023 – plenary drugs day 1